Vivani Medical, Inc. (NASDAQ:VANI)
| Market Cap | 101.03M-40.1% |
| Revenue (ttm) | 0 |
| Net Income | -26.31M-3.0% |
| EPS | -0.35+22.2% |
| Shares Out | 90.20M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 80,399 |
| Open | 1.14 |
| Previous Close | 1.12 |
| Day's Range | 1.12 - 1.14 |
| 52-Week Range | 0.92 - 1.92 |
| Beta | 3.28 |
| Analysts | Buy |
| Price Target | 4.00(+257.14%) |
| Earnings Date | Nov 12, 2026 |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About VANI
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
$VANI stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in VANI holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by VANI's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
VANI Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New VANI patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to VANI from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in VANI
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.38M |
| VXFVanguard Extended Market ETF | $404.64K |
| IWCiShares Micro-Cap ETF | $139.90K |
Estimated from each fund’s disclosed top holdings × AUM
VANI Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from VANI’s recent data — informational, not investment advice